
- Gold sponsorship boosts brand presence, accelerates global expansion in medical aesthetics
- Flagship brand 'RICHESSE™ ' draws international buyers with next-gen skin boosters and toxin products
JDBIO, a global leader in medical aesthetics, took part as a Gold Sponsor at AMWC Monaco 2026, held from March 26–28 at the Grimaldi Forum. The company highlighted its advanced technologies and competitive product portfolio, earning strong positive feedback from industry professionals worldwide.
Widely regarded as one of the most influential events in aesthetics and anti-aging, AMWC Monaco brings together more than 10,000 medical professionals and around 500 speakers each year. With a strong focus on practicing clinicians, the congress serves as a key platform for gauging real-time market response and sharing the latest clinical insights.
JDBIO operated a large booth near the entrance of the Atrium Hall, featuring a sleek, brand-driven design that drew steady foot traffic. The display included its flagship brand RICHESSE™—fronted by Super Junior’s Leeteuk—as well as core brands such as DEMEI™, alongside newly launched toxin and skin booster lines.
Visitors showed particular interest in the quality and value of Korean medical aesthetics products. Exosome-based skin boosters and PN-based formulations generated consistent attention, while RICHESSE™ Red Volume, a filler designed specifically for lip enhancement, proved especially popular among practitioners from Latin America.
Earlier in March, JDBIO also exhibited at KIMES 2026 at COEX in Seoul, where it hosted a 74㎡ booth featuring an experiential “JD BAR.” The space allowed visitors to relax with drinks while engaging with the brand, offering a more immersive alternative to traditional exhibition formats. The approach was well received for creating a comfortable environment for both product consultations and brand engagement.
A JDBIO representative said, “AMWC Monaco reaffirmed the high level of trust global medical professionals place in our products. We will continue to invest in R&D and expand our presence at leading international congresses as we grow into a comprehensive global beauty solutions provider spanning both medical aesthetics and cosmetics.”

